Genfit
GNFT
GNFT was delisted on the 19th of November, 2025.
30 hedge funds and large institutions have $139M invested in Genfit in 2019 Q1 according to their latest regulatory filings, with 30 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
18.57% more ownership
Funds ownership: 0% → 18.57% (+19%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$28.4M |
| 2 |
O
OrbiMed
New York
|
+$28.4M |
| 3 |
CH
CVI Holdings
Wilmington,
Delaware
|
+$9.23M |
| 4 |
BlackRock
New York
|
+$8.33M |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$8.08M |
Top Sellers
GNFT Hedge Fund Activity: Q1 2019 in Review
30 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Genfit (GNFT) for Q1 2019, worth a combined $139M.
Buyers outnumbered sellers: 30 funds opened new GNFT positions and 0 closed out — a net gain of 30 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Great Point Partners, opening a new position worth an estimated $28.4M.
- 30 institutional investors held Genfit (GNFT) as of Q1 2019, up from 0 in Q4 2018.
- Funds reported $139M of Genfit stock for Q1 2019.
- 30 funds opened new Genfit positions in Q1 2019 and 0 closed out, a net change of +30 holders.
- The largest Genfit buyer in Q1 2019 was Great Point Partners, an estimated $28.4M added.
Based on aggregated 13F filings for Q1 2019.